Affordable medicine, smarter insurance: The blueprint for lowering India’s healthcare costs Susheel Agarwal highlights the transformative potential of aligning health insurance with generic drug adoption to reduce…
Stereotaxis GenesisX EU nod marks major shift in robotic-assisted surgery market: GlobalData Stereotaxis GenesisX EU clearance signals pivotal advancement in robotic-assisted surgery, highlighting the industry's shift…
Pharma companies need to limit the presence of nitrosamines in human medicines: EMA Patients should generally not be exposed to a lifetime risk of cancer exceeding 1 in 100,000 from nitrosamines in their medicines
Faulty Medical Devices: A Value Chain gone Berserk? Prashant K Singh, Director, Coordination and Strategy Development, at the Public Health Foundation of India. expounds on how…